"Inhibition of Lysine Deacetylase Activity Impacts Formation of the Vit" by Shannon Dwyer

Date Approved

2-1-2025

Embargo Period

3-24-2025

Document Type

Dissertation

Degree Name

Doctor of Philosophy (Ph.D.)

Department

Cell Biology and Neuroscience

College

Rowan-Virtua School of Translational Biomedical Engineering & Sciences

Advisor

Vincent Manna, PhD

Committee Member 1

Salvatore Caradonna, PhD

Committee Member 2

Susan Muller-Weeks, PhD

Committee Member 3

Ronald E. Ellis, PhD

Committee Member 4

Katharine Milani, PhD

Committee Member 5

Valerie Carabetta, PhD

Disciplines

Biochemistry | Biochemistry, Biophysics, and Structural Biology | Life Sciences

Abstract

The vitamin D endocrine system is responsible for the regulation of many biological processes including bone metabolism, calcium homeostasis, cell proliferation and cell differentiation. Alterations to the vitamin D signaling pathway are associated with several diseases including bone diseases, diabetes, cardiovascular diseases, autoimmune diseases, and cancer. Vitamin D precursors are chemically modified to become the biologically active hormone, calcitriol. Calcitriol binds to the vitamin D receptor (VDR), a member of the nuclear hormone receptor (NHR) superfamily. VDR forms a heterodimer with retinoid X receptor (RXR) and together they bind to promoters containing vitamin D response elements (VDREs) to activate transcription of target genes. Other NHRs have been shown to be post-translationally modified that can either increase or decrease their transcriptional output through alterations in protein-protein or protein-DNA interactions. I have generated evidence that two lysines on VDR are likely to be targets of acetylation, and alterations to lysine deacetylase activity impacts VDR transcriptional output through changes in co-activator and co-repressor binding. Together, these data suggest a novel way for the cell to modulate the response of VDR to available vitamin D.

Included in

Biochemistry Commons

Share

COinS